Bruno Halpern

49 papers receiving 952 citations

Bruno Halpern's Hit Papers

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment 2025 · 28 citations
280+1+2Years since publication50100150200250

Peers

Bruno Halpern
Comparison fields: 5 of 93
  • Endocrinology, Diabetes and Metabolism 331
  • Endocrine and Autonomic Systems 96
  • Pharmacology 212
  • Physiology 254
  • Pharmacy 31
Replace Shannon C. Kelly with:
Shannon C. Kelly United States
Nader Lessan United Kingdom
L. Van Gaal Belgium
Katherine H. Saunders United States
Martin Bæk Blond Denmark
Amélio F. Godoy‐Matos Brazil
S. John Weisnagel Canada
Katrine Bagge Hansen Denmark
Meera Shah United States
Charlotte Janus Denmark
Bruno Halpern relative to Shannon C. Kelly United States Shannon C. Kelly's profile →
Citations per field
00.5×5.4×
Shannon C. Kelly · 1×
Citations per year

Countries citing papers authored by Bruno Halpern

Since Specialization
Citations

This map shows the geographic impact of Bruno Halpern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Halpern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Halpern more than expected).

Fields of papers citing papers by Bruno Halpern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Halpern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Halpern. The network helps show where Bruno Halpern may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruno Halpern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruno Halpern Line = papers co-authored together Bruno Halpern links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
Hit paper breakdown →
2023265
2
Tirzepatide for Obesity Treatment and Diabetes Prevention
Hit paper breakdown →
2024197
3 201951
4 202050
5 201534
6 201634
7 202231
8 202431
9
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
Hit paper breakdown →
202528
10 201926
11 201024
12 202219
13 201419
14 202114
15 202013
16 202312
17
Further studies on the nature of the hemorrhagic state in radiation injury.
195212
18 201911
19 20209
20 20209

About Bruno Halpern

Bruno Halpern is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Pharmacology, Surgery and Pharmacy, having authored 52 papers that have together received 983 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Diet and metabolism studies (11 papers), Pharmacology and Obesity Treatment (10 papers), Obesity and Health Practices (9 papers), Bariatric Surgery and Outcomes (7 papers), Adipose Tissue and Metabolism (6 papers), Obesity, Physical Activity, Diet (3 papers) and Circadian rhythm and melatonin (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (331 citations), Endocrine and Autonomic Systems (96 citations), Pharmacology (212 citations), Physiology (254 citations) and Pharmacy (31 citations). Bruno Halpern has collaborated with scholars based in Brazil, United States and United Kingdom. Frequent co-authors include Márcio C. Mancini, Nadia N. Ahmad, Shuyu Zhang, Alfredo Halpern, Mathijs C. Bunck, Ariana M. Chao, Thomas A. Wadden, Jamy D. Ard, Sriram Machineni and Jiaxun Chen. Their work appears in journals such as Diabetology & Metabolic Syndrome, Expert Opinion on Drug Safety, Reviews in Endocrine and Metabolic Disorders, Obesity Research & Clinical Practice and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact